title: Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.
abstract: BACKGROUND
  Non-alcoholic fatty liver disease is prevalent in affluent countries and is strongly associated with metabolic syndrome.
  
  
  OBJECTIVE
  To study the prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.
  
  
  METHODS
  73 consecutive patients with biopsy-proven non-alcoholic fatty liver disease and no history of diabetes underwent comprehensive metabolic screening. Diagnosis of diabetes and impaired glucose regulation was based on the 2006 American Diabetes Association criteria.
  
  
  RESULTS
  The prevalence of undiagnosed diabetes and impaired glucose tolerance in non-alcoholic fatty liver disease patients was 33% and 29%, respectively. Among patients with 2-h plasma glucose above 7.8 mm, 47% had normal fasting glucose (below 5.6 mm). Impaired glucose tolerance was more common in patients with non-alcoholic steatohepatitis than those with simple hepatic steatosis (P = 0.036), and 2-h plasma glucose correlated with fibrosis stage (Spearman coefficient: 0.25, P = 0.046). In a binary logistic regression analysis, high fasting glucose and low high-density lipoprotein cholesterol were independent factors associated with diabetes. Nevertheless, if oral glucose tolerance test was only performed in non-alcoholic fatty liver disease patients with impaired fasting glucose, 20.8% of diabetes cases would be missed.
  
  
  CONCLUSIONS
  Isolated postchallenge hyperglycaemia is common among Chinese non-alcoholic fatty liver disease patients without history of diabetes. It is associated with histological severe disease, and cannot be accurately predicted by any fasting glucose cut-off.
authors.affiliation: Institute of Digestive Diseases, The Chinese University of Hong Kong, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, Hong Kong SAR.
authors.forename: V W S
authors.initials: VW
authors.lastname: Wong
authors.forename: A Y
authors.initials: AY
authors.lastname: Hui
authors.forename: S W C
authors.initials: SW
authors.lastname: Tsang
authors.forename: J L Y
authors.initials: JL
authors.lastname: Chan
authors.forename: G L H
authors.initials: GL
authors.lastname: Wong
authors.forename: A W H
authors.initials: AW
authors.lastname: Chan
authors.forename: W Y
authors.initials: WY
authors.lastname: So
authors.forename: A Y S
authors.initials: AY
authors.lastname: Cheng
authors.forename: P C Y
authors.initials: PC
authors.lastname: Tong
authors.forename: F K L
authors.initials: FK
authors.lastname: Chan
authors.forename: J J Y
authors.initials: JJ
authors.lastname: Sung
authors.forename: H L Y
authors.initials: HL
authors.lastname: Chan
mesh_terms: D001786:Blood Glucose / Q000032:analysis; D008076:Cholesterol, HDL / Q000097:blood; D048909:Diabetes Complications / Q000175:diagnosis* / Q000453:epidemiology / Q000473:pathology; D005234:Fatty Liver / Q000150:complications* / Q000453:epidemiology / Q000473:pathology; D005260:Female; D005951:Glucose Tolerance Test / Q000379:methods; D006723:Hong Kong / Q000453:epidemiology; D006801:Humans; D006943:Hyperglycemia / Q000150:complications* / Q000453:epidemiology / Q000473:pathology; D007333:Insulin Resistance; D008099:Liver / Q000473:pathology; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011446:Prospective Studies
chemical_list: D001786:Blood Glucose; D008076:Cholesterol, HDL